Related references
Note: Only part of the references are listed.Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise
Fei Yin
FEBS JOURNAL (2023)
Lysophospholipid Mediators in Health and Disease
Kuniyuki Kano et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)
Lysophosphatidylcholine disrupts cell adhesion and induces anoikis in hepatocytes
Hao Chen et al.
FEBS LETTERS (2022)
Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ1-42 through inhibiting RhoA/ROCK2 pathway
XiaoTong Xiang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease commentary
Kentaro Yoshioka et al.
KIDNEY INTERNATIONAL (2022)
Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions
Simon C. Dyall et al.
PROGRESS IN LIPID RESEARCH (2022)
Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis
Makoto Kurano et al.
CANCER MEDICINE (2022)
Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer's disease
Vladimir Rudajev et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)
Gintonin facilitates brain delivery of donepezil, a therapeutic drug for Alzheimer disease, through lysophosphatidic acid 1/3 and vascular endothelial growth factor receptors
Sun-Hye Choi et al.
JOURNAL OF GINSENG RESEARCH (2021)
24S-hydroxycholesterol: Cellular effects and variations in brain diseases
Alejandro O. Sodero
JOURNAL OF NEUROCHEMISTRY (2021)
Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis
Baasanjav Uranbileg et al.
SCIENTIFIC REPORTS (2021)
Sphingolipids in metabolic disease: The good, the bad, and the unknown
Christopher D. Green et al.
CELL METABOLISM (2021)
Lysophosphatidylinositol, especially albumin-bound form, induces inflammatory cytokines in macrophages
Makoto Kurano et al.
FASEB JOURNAL (2021)
Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy
Yoshifumi Morita et al.
JOURNAL OF LIPID RESEARCH (2021)
Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms
Yang Shi et al.
NEURON (2021)
The Combined Effects of Lysophospholipids against Lipopolysaccharide-induced Inflammation and Oxidative Stress in Microglial Cells
Tamotsu Tsukahara et al.
JOURNAL OF OLEO SCIENCE (2021)
Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy
Yoshifumi Morita et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models
Fulvio R. Mendes et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer's Disease: From Physiological Performance to Pathological Impairment
Yining Hao et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer's Disease
Arti Tyagi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease
Shahzad Ahmad et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Establishment of a Measurement System for Sphingolipids in the Cerebrospinal Fluid Based on Liquid Chromatography-Tandem Mass Spectrometry, and Its Application in the Diagnosis of Carcinomatous Meningitis
Eri Sakai et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
An accurate and versatile method for determining the acyl group-introducing position of lysophospholipid acyltransferases
Hiroki Kawana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)
Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis
Tomoaki Ishihara et al.
INTERNATIONAL IMMUNOLOGY (2019)
Identification of P2Y receptors involved in oleamide-suppressing inflammatory responses in murine microglia and human dendritic cells
Masahiro Kita et al.
SCIENTIFIC REPORTS (2019)
GPR34 in spinal microglia exacerbates neuropathic pain in mice
Akira Sayo et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Redox state of albumin affects its lipid mediator binding characteristics
Makoto Kurano et al.
FREE RADICAL RESEARCH (2019)
Evaluation of Lysophospholipid Measurement in Cerebrospinal Fluid Samples using Liquid Chromatography-Tandem Mass Spectrometry
Yoshifumi Morita et al.
LIPIDS (2019)
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Andreane Cartier et al.
SCIENCE (2019)
The leukotriene receptors as therapeutic targets of inflammatory disease
Fumiyuki Sasaki et al.
INTERNATIONAL IMMUNOLOGY (2019)
Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis
Xiaoyang Zhang et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P2 and S1P3 Expression in Colon Cancer
Baasanjav Uranbileg et al.
CLINICAL COLORECTAL CANCER (2018)
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma et al.
PLOS MEDICINE (2018)
Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
Soraya Wilke Saliba et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome
Makoto Kurano et al.
JOURNAL OF LIPID RESEARCH (2017)
Analysis of glycero-lysophospholipids in gastric cancerous ascites
Shigenobu Emoto et al.
JOURNAL OF LIPID RESEARCH (2017)
Alzheimer's brains show inter-related changes in RNA and lipid metabolism
Shahar Barbash et al.
NEUROBIOLOGY OF DISEASE (2017)
Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study
Stuart G. Snowden et al.
PLOS MEDICINE (2017)
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Mingqin Zhu et al.
MOLECULAR NEUROBIOLOGY (2016)
Apoptosis of Endothelial Cells by 13-HPODE Contributes to Impairment of Endothelial Barrier Integrity
Valerie E. Ryman et al.
MEDIATORS OF INFLAMMATION (2016)
Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage
Rasoul Ghasemi et al.
PHARMACOLOGICAL RESEARCH (2016)
Oxysterols: From cholesterol metabolites to key mediators
Valentin Mutemberezi et al.
PROGRESS IN LIPID RESEARCH (2016)
Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels
Kenichiro Enooku et al.
PLOS ONE (2016)
Metabolic regulation by secreted phospholipase A(2)
Hiroyasu Sato et al.
INFLAMMATION AND REGENERATION (2016)
Effect of phosphatidylserine on memory in patients and rats with Alzheimer's disease
Y. Y. Zhang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders
Adrian D. Hobson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord
Adam T. Guy et al.
SCIENCE (2015)
Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids
Makoto Kurano et al.
BBA CLINICAL (2015)
Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome
Makoto Kurano et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Novel lysophosphoplipid receptors: their structure and function
Kumiko Makide et al.
JOURNAL OF LIPID RESEARCH (2014)
Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease
Yoko Tajima et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Alterations in phosphatidylethanolamine levels affect the generation of Aß
Iva Nesic et al.
AGING CELL (2012)
Triangulated Mal-Signaling in Alzheimer's Disease: Roles of Neurotoxic Ceramides, ER Stress, and Insulin Resistance Reviewed
Suzanne M. de la Monte
JOURNAL OF ALZHEIMERS DISEASE (2012)
Increased Ceramide in Brains with Alzheimer's and Other Neurodegenerative Diseases
Valery Filippov et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
Asuka Inoue et al.
NATURE METHODS (2012)
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease
Gehua Zhen et al.
NEUROBIOLOGY OF AGING (2012)
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease
Kwang-Mook Jung et al.
NEUROBIOLOGY OF AGING (2012)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
Formation and function of apolipoprotein E-containing lipoproteins in the nervous system
Jean E. Vance et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Lipid Alterations in Lipid Rafts from Alzheimer's Disease Human Brain Cortex
Virginia Martin et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Deregulation of sphingolipid metabolism in Alzheimer's disease
Xingxuan He et al.
NEUROBIOLOGY OF AGING (2010)
Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's Disease
Giuseppe Astarita et al.
PLOS ONE (2010)
Bioactive sphingolipids: metabolism and function
Nana Bartke et al.
JOURNAL OF LIPID RESEARCH (2009)
Identification of GPR55 as a lysophosphatidylinositol receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease
Ikuko Mohri et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Lipids as modulators of proteolytic activity of BACE - Involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro
L Kalvodova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis
H Satoi et al.
NEUROSCIENCE (2005)
Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-κB)
RS Dwarakanath et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuropathological diagnostic criteria for Alzheimer's disease
S Murayama et al.
NEUROPATHOLOGY (2004)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Sphingosine kinase, sphingosine-1-phosphate, and apoptosis
M Maceyka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
15(S)-HETE modulates LTB4 production and neutrophil chemotaxis in chronic bronchitis
M Profita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
Share Paper
